Focuses – Care Harbor

Skye Nixes Eye Disease Drug After Phase II Failure, Focuses on Metabolic Program

Pictured: Healthcare worker conducting an eye exam on a female patient/iStock, peakSTOCK Skye Bioscience announced Monday it…